Proportion of infants who develop epilepsy post‐discharge · neonates with EEG‐confirmed seizures
It is very uncertain whether summary of findings table ‐ Phenobarbital changes proportion of infants who develop epilepsy post‐discharge compared with levetiracetam (very low certainty).
1 finding from 1 review
Proportion of infants who achieve seizure control after the first loading dose of ASM · neonates with clinically diagnosed seizures
It is very uncertain whether summary of findings table ‐ Phenobarbital changes proportion of infants who achieve seizure control after first… compared with levetiracetam (very low certainty).
1 finding from 1 review
Proportion of infants who achieve seizure control after maximal loading dose of ASM · neonates with clinically diagnosed seizures
It is very uncertain whether summary of findings table ‐ Phenobarbital changes proportion of infants who achieve seizure control after maximal… compared with levetiracetam (very low certainty).
1 finding from 1 review
Dead or dependent · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant showed no clear difference in dead or dependent at end of compared with control (high certainty).
1 finding from 1 review
Death during study period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant showed no clear difference in death from all causes during treatment period compared with control (low certainty).
1 finding from 1 review
Deep vein thrombosis · acute presumed ischaemic stroke
It is very uncertain whether summary of findings table ‐ Anticoagulant changes deep vein thrombosis during treatment period compared with control (very low certainty).
1 finding from 1 review
Recurrent ischaemic or unknown stroke during treatment period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant probably leads to lower recurrent ischaemic or unknown stroke during treatment period compared with control (moderate certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage during treatment period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant probably leads to higher symptomatic intracranial haemorrhage during treatment period compared with control (moderate certainty).
1 finding from 1 review
Symptomatic PE · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant leads to lower symptomatic pulmonary embolism during treatment period compared with control (high certainty).
1 finding from 1 review
Major extracranial haemorrhage during treatment period · acute presumed ischaemic stroke
Summary of findings table ‐ Anticoagulant probably leads to higher major extracranial haemorrhage during treatment period compared with control (moderate certainty).
1 finding from 1 review
Upper limb function · adults with dorsally displaced distal radius fractures
3 findings from 1 review
Number of people incurring one or more complications requiring substantive treatment · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Overall number of people incurring one or more complications · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Grip strength ‐ Vitamin D · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · adults with dorsally displaced distal radius fractures
1 finding from 1 review
Pulmonary exacerbations number of participants requiring IV antibiotics · children with cystic fibrosis
Summary of findings: Zinc supplementation showed no clear difference in pulmonary exacerbations number of participants requiring IV… compared with placebo (moderate certainty).
1 finding from 1 review
FEV1 % predicted · children with cystic fibrosis
It is very uncertain whether summary of findings: Zinc supplementation changes respiratory function mean FEV1 % predicted compared with placebo (very low certainty).
1 finding from 1 review
Adverse events number of participants hospitalised during the trial · children with cystic fibrosis
Summary of findings: Zinc supplementation showed no clear difference in adverse events number of participants hospitalised during the trial compared with placebo (moderate certainty).
1 finding from 1 review
Need for antibiotics days of antibiotic use · children with cystic fibrosis
It is very uncertain whether summary of findings: Zinc supplementation changes need for antibiotics number of days on IV or oral antibiotics compared with placebo (very low certainty).
1 finding from 1 review
QoL · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found